Wagner, Carsten A.
University of Zurich
14 papers on CoChatORCID 0000-0002-9874-8898
Most cited papers
- Verified
Mechanisms of cognitive dysfunction in CKD
Viggiano, D., Wagner, C. A., Martino, G., Nedergaard, M., Zoccali, C., Unwin, R., & Capasso, G. (2020) · Nature Reviews Nephrology
Dementia and Cognitive Impairment ResearchDialysis and Renal Disease Management
Cited by 392
- Verified
Mechanisms of phosphate transport
Levi, M., Gratton, E., Forster, I. C., Hernando, N., Wagner, C. A., Biber, J., Sorribas, V., & Murer, H. (2019) · Nature Reviews Nephrology
Parathyroid Disorders and TreatmentsIon Transport and Channel Regulation
Cited by 171
- Verified
Up-regulation of FGF23 release by aldosterone
Zhang, B., Umbach, A. T., Chen, H., Yan, J., Fakhri, H., Fajol, A., Salker, M. S., Spichtig, D., Daryadel, A., Wagner, C. A., et al. (2016) · Biochemical and Biophysical Research Communications
Parathyroid Disorders and TreatmentsHormonal Regulation and Hypertension
Cited by 91
- Verified
Activation of dopamine D 1 -like receptors induces acute internalization of the renal Na + /phosphate cotransporter NaPi-IIa in mouse kidney and OK cells
Bacic, D., Capuano, P., Baum, M., Zhang, J., Stange, G., Biber, J., Kaissling, B., Moe, O. W., Wagner, C. A., & Murer, H. (2005) · American Journal of Physiology-Renal Physiology
Ion Transport and Channel RegulationParathyroid Disorders and Treatments
Cited by 76
- Verified
Renal phosphate handling and inherited disorders of phosphate reabsorption: an update
Wagner, C. A., Rubio-Aliaga, I., & Hernando, N. (2019) · Pediatric Nephrology
Parathyroid Disorders and TreatmentsIon Transport and Channel Regulation
Cited by 73
- Verified
Mechanisms and Regulation of Intestinal Phosphate Absorption
Hernando, N., & Wagner, C. A. (2018) · Comprehensive Physiology
Parathyroid Disorders and TreatmentsIon Transport and Channel Regulation
Cited by 70
- Verified
Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3
Kägi, L., Bettoni, C., Pastor-Arroyo, E. M., Schnitzbauer, U., Hernando, N., & Wagner, C. A. (2018) · PLOS ONE
Parathyroid Disorders and TreatmentsVitamin D Research Studies
Cited by 46
- Verified
Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo
Küng, C. J., Haykir, B., Schnitzbauer, U., Egli-Spichtig, D., Hernando, N., & Wagner, C. A. (2021) · American Journal of Physiology-Renal Physiology
Parathyroid Disorders and TreatmentsIon Transport and Channel Regulation
Cited by 38
- Verified
A chronic high phosphate intake in mice is detrimental for bone health without major renal alterations
Ugrica, M., Bettoni, C., Bourgeois, S., Daryadel, A., Pastor-Arroyo, E.-M., Gehring, N., Hernando, N., Wagner, C. A., & Rubio-Aliaga, I. (2021) · Nephrology Dialysis Transplantation
Parathyroid Disorders and TreatmentsBone health and osteoporosis research
Cited by 17
- Verified
Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels
Gerber, J. S., Arroyo, E. M. P., Pastor, J., Correia, M., Rudloff, S., Moe, O. W., Egli-Spichtig, D., Mohebbi, N., & Wagner, C. A. (2025) · Pflügers Archiv - European Journal of Physiology
Parathyroid Disorders and TreatmentsBone health and osteoporosis research
Cited by 15
- Verified
Acute adaptation of renal phosphate transporters in the murine kidney to oral phosphate intake requires multiple signals
Daryadel, A., Haykir, B., Küng, C. J., Bugarski, M., Bettoni, C., Schnitzbauer, U., Hernando, N., Hall, A. M., & Wagner, C. A. (2022) · Acta Physiologica
Parathyroid Disorders and TreatmentsIon Transport and Channel Regulation
Cited by 14
- Verified
Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients
Egli-Spichtig, D., Hamid, A. K., Arroyo, E. M. P., Ketteler, M., Wiecek, A., Rosenkranz, A. R., Pasch, A., Lorenz, H., Hellmann, B., Karus, M., et al. (2023) · Clinical Kidney Journal
Parathyroid Disorders and TreatmentsDialysis and Renal Disease Management
Cited by 9
- Verified
Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation
Radvanyi, Z., Yoo, E. J., Kandasamy, P., Salas-Bastos, A., Monnerat, S., Refardt, J., Christ-Crain, M., Hayashi, H., Kondo, Y., Jantsch, J., et al. (2024) · Journal of Biological Chemistry
Parathyroid Disorders and TreatmentsBone Metabolism and Diseases
Cited by 9
- Verified
Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling
Egli-Spichtig, D., Zhang, M. Y. H., Li, A., Pastor Arroyo, E. M., Hernando, N., Wagner, C. A., Chang, W., & Perwad, F. (2021) · Scientific Reports
Parathyroid Disorders and TreatmentsAlkaline Phosphatase Research Studies
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free